Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Mar-Apr:52:95-105.
doi: 10.1016/j.hrtlng.2021.11.011. Epub 2021 Dec 13.

A systematic review and metanalysis of diagnostic yield of BAL for detection of SARS-CoV-2

Sumita Agrawal  1 , Akhil Dhanesh Goel  2 , Nitesh Gupta  3 , Hari Kishan Gonuguntla  4 , Henri Colt  5
Affiliations
Meta-Analysis

A systematic review and metanalysis of diagnostic yield of BAL for detection of SARS-CoV-2

Sumita Agrawal et al. Heart Lung. 2022 Mar-Apr.

Abstract

Background: The gold standard for diagnosing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is microbiological confirmation by reverse transcriptase-polymerase chain reaction (RT-PCR)1 most commonly done using oropharyngeal (OP) and nasopharyngeal swabs (NP). But in suspected cases, where these samples are false-negative, bronchoalveolar lavage (BAL) may prove diagnostic.

Objectives: Hence, the diagnostic yield of BAL for detection of SARS-CoV-2 in cases of non-diagnostic upper respiratory tract samples is reviewed.

Methods: Databases such as MEDLINE, Scopus, and Google Scholar were searched using a systematic search strategy. The current study has been in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines and has been registered with the International Prospective Registry of Systematic Reviews (CRD42020224088).

Results: 911 records were identified at initial database extraction, of which 317 duplicates were removed and, 596 records were screened for inclusion eligibility. We included total 19 studies in the systematic review, and 17 were included in metanalysis. The pooled estimate of SARS-CoV-2 positivity in BAL was 11% (95%CI: 0.01-0.24). A sensitivity analysis also showed that the results appear to be robust and minimal risk of bias amongst the studies.

Conclusion: The current study demonstrates that BAL can be used to diagnose additional cases primary disease and superadded infections in patients with severe COVID-19 lower respiratory tract infection.

Keywords: Bronchoalveolar Lavage; COVID-19; COVID-19 diagnostic testing [Supplementary Concept]; SARS-CoV-2.

PubMed Disclaimer

Figures

Fig 1
Fig. 1
PRISMA flow diagram depicting the flow of information through different phases of systematic review.
Fig 2
Fig. 2
Forest plot representing the pooled estimate of SARS-CoV2 positivity in BAL.
Fig 3
Fig. 3
DOI plot representing the robustness of estimate.
Fig 4
Fig. 4
Influential analysis.
Fig 5
Fig. 5
Risk of bias.
See this image and copyright information in PMC

References

    1. World Health Organization; Geneva: 2020. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. https://apps.who.int/iris/bitstream/handle/10665/331501/WHO-COVID-19-lab...
    1. Yang Y., Yang M., Shen C., Wang F., Yuan J., Li J. Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections. medRxiv. 2020 doi: 10.1101/2020.02.11.20021493. [cited 2021 Jan 27] - DOI
    1. Turriziani O., Sciandra I., Mazzuti L., Di Carlo D., Bitossi C., Calabretto M. SARS-CoV-2 diagnostics in the virology laboratory of a university hospital in rome during the lockdown period. J Med Virol. 2021;93(2):886–891. - PMC - PubMed
    1. Chang J., Swenson K.E., Sung A., Bedi H. Coronavirus disease 2019 test correlation between nasopharyngeal swab and BAL in asymptomatic patients. Chest. 2020:110–112. doi: 10.1016/j.chest.2020.11.006. - DOI - PMC - PubMed
    1. Wang W., Xu Y., Gao R., Lu R., Han K., Wu G. Detection of SARS-CoV-2 in different types of clinical specimens. JAMA J Am Med Assoc. 2020;323(18):1843–1844. - PMC - PubMed